In 2017 (W7), when eGFR results were captured, approximately one in five patients with type 2 diabetes treated with OGLDs alone, one in three patients with insulin-treated type 2 diabetes and one in ten patients with type 1 diabetes had CKD stage 3 or above. Here, INS is linked to chronic kidney disease.